Suppr超能文献

同步原发性子宫内膜癌和卵巢癌的临床病理及生存分析

[Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].

作者信息

Wang Y, Yu M, Yang J X, Cao D Y, Zhang Y, Shen K, You Y

机构信息

Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.

出版信息

Zhonghua Fu Chan Ke Za Zhi. 2018 Dec 25;53(12):816-822. doi: 10.3760/cma.j.issn.0529-567x.2018.12.004.

Abstract

To demonstrate the clinicopathological characteristics and determine the prognostic factors for women with synchronous primary endometrial and ovarian cancer (SEOC) . A retrospective analysis of 63 pathologically proven cases of SEOC diagnosed in Peking Union Medical College Hospital from January 2000 to May 2018 was carried out. (1) Clinical features: mean age at diagnosis was (48.3±10.0) years, and the mean body mass index (BMI) was (23.4±3.7) kg/m(2). The most common presenting symptom was abnormal uterine bleeding with a ratio of 73% (46/63). Forty-three patients (68%, 43/63) were premenopausal, and 30% (19/63) were nulliparous. (2) Pathological features: for the endometrial cancer, 90% patients were diagnosed at stage Ⅰ, and 81% were low grade tumors (G(1)-G(2)). The histological type of endometrial cancer was mainly endometrioid carcinoma (86%) and majority (81%) of patients were proved without or with superficial myometrial invasion. For the ovarian cancer, 70% patients were diagnosed at stage Ⅰ and 65% were low grade tumors (G(1)-G(2)). Sixty-two percent of ovarian cancers were endometrioid carcinoma and 68% of patients had unilateral involvement of the ovaries. (3) Treatment and prognosis: all patients underwent surgery, of which 56 (89%) underwent staging surgery including retroperitoneal lymphadenectomy, and 57 (90%) received postoperative adjuvant therapy. The median follow-up time was 48.0 months (range, 2-176 months) , and 13% of the patients experienced tumor recurrence during the follow-up period. The median time to recurrence was 38.5 months, and 6 patients (10%) died of tumor recurrence. The 5-year progression-free survival (PFS) and 5-year overall survival (OS) for all patients were 69% and 80%, respectively. (4) Prognostic factors: univariate analysis showed that the presence of lymphovascular space invasion (LVSI) , non-endometrioid histology of ovarian cancer and stage of ovarian cancer above stage Ⅰ were associated with significantly worse PFS (0.05). LVSI, high grade of endometrial cancer, and above stage Ⅰ of ovarian cancer were associated with significantly worse OS (0.05). On multivariate analysis, LVSI, non-endometrioid type ovarian cancer and stage of ovarian cancer above stage Ⅰwere associated with significantly worse PFS (0.05). In addition, LVSI and stage of ovarian cancer above stage Ⅰ were also associated with significantly worse OS (0.05) . Women with SEOC are young, premenopausal and have a favorable overall prognosis. Presence of LVSI, non-endometrioid type ovarian cancer and stage of ovarian cancer above stage Ⅰ are independent prognostic factors for PFS, and stage of ovarian cancer above stage Ⅰare independent prognostic factors for OS.

摘要

为了阐明同步原发性子宫内膜癌和卵巢癌(SEOC)女性患者的临床病理特征并确定其预后因素。对2000年1月至2018年5月在北京协和医院确诊的63例经病理证实的SEOC病例进行了回顾性分析。(1)临床特征:诊断时的平均年龄为(48.3±10.0)岁,平均体重指数(BMI)为(23.4±3.7)kg/m²。最常见的症状是子宫异常出血,比例为73%(46/63)。43例患者(68%,43/63)为绝经前,19例(30%,19/63)未生育。(2)病理特征:对于子宫内膜癌,90%的患者诊断为Ⅰ期,81%为低级别肿瘤(G1-G2)。子宫内膜癌的组织学类型主要为子宫内膜样癌(86%),大多数患者(81%)被证实无肌层浸润或仅有浅肌层浸润。对于卵巢癌,70%的患者诊断为Ⅰ期,65%为低级别肿瘤(G1-G2)。62%的卵巢癌为子宫内膜样癌,68%的患者单侧卵巢受累。(3)治疗与预后:所有患者均接受了手术,其中56例(89%)接受了分期手术,包括腹膜后淋巴结清扫术,57例(90%)接受了术后辅助治疗。中位随访时间为48.0个月(范围2-176个月),13%的患者在随访期间出现肿瘤复发。复发的中位时间为38.5个月,6例患者(10%)死于肿瘤复发。所有患者的5年无进展生存率(PFS)和5年总生存率(OS)分别为69%和80%。(4)预后因素:单因素分析显示,存在脉管间隙浸润(LVSI)、卵巢癌非子宫内膜样组织学类型以及卵巢癌Ⅰ期以上与PFS显著较差相关(P<0.05)。LVSI、子宫内膜癌高级别以及卵巢癌Ⅰ期以上与OS显著较差相关(P<0.05)。多因素分析显示,LVSI、非子宫内膜样型卵巢癌以及卵巢癌Ⅰ期以上与PFS显著较差相关(P<0.05)。此外,LVSI和卵巢癌Ⅰ期以上也与OS显著较差相关(P<0.05)。SEOC女性患者年轻、绝经前,总体预后良好。存在LVSI、非子宫内膜样型卵巢癌以及卵巢癌Ⅰ期以上是PFS的独立预后因素,卵巢癌Ⅰ期以上是OS的独立预后因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验